ArticleFrontiers in cardiovascular medicine2026
Case Report: Exploring KMT2D mutation in Shone syndrome.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Shone syndrome is a rare congenital heart disease characterized by multilevel left-sided obstructive lesions. KMT2D variants cause Kabuki syndrome and are frequently associated with left-sided obstructive congenital heart defects, but their contribution to Shone syndrome remains uncertain. Methods: We report a 4-year-old girl with a Shone syndrome phenotype. Trio whole-exome sequencing (WES) was performed in the proband and her parents, with Sanger sequencing for confirmation and segregation analysis. Echocardiography and CT angiography were used to delineate cardiac anatomy. Results: Imaging and intraoperative findings demonstrated a supramitral ring with mitral stenosis, abnormal subvalvular apparatus, an interrupted/hypoplastic aortic arch with extensive collateral circulation, and a bicuspid aortic valve. Trio-WES identified a heterozygous KMT2D variant (NM_003482.4:c.15565G > A, p.Gly5189Arg) in the proband, which was also present in her clinically unaffected mother and younger sister, indicating maternal inheritance with variable expressivity. Conclusions: This report describes a child with multilevel left-sided obstruction and an inherited KMT2D variant, together with limited Kabuki-like facial features that did not meet the 2019 international consensus clinical criteria for Kabuki syndrome. While the observation raises the possibility that KMT2D-related pathways may contribute to Shone complex, a causal relationship cannot be inferred from a single family and requires additional genetic and functional studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.